Drawing for PIERIAN

USPTO serial 87043111

PIERIAN

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
SMITH, BRIDGETT G
Law office
TTAB

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 604: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with PIERIAN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jessica L. Rothstein

JESSICA L ROTHSTEIN GOODWIN PROCTER LLP620 EIGHTH AVENUENEW YORK, NY 10018UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Drug testing kits comprised of medical diagnostic reagents and assays for testing specimens; medical diagnostic reagents and assays for testing of body specimens; medical diagnostic reagents and assays for testing of cytotoxic, targeted biologic and immunotherapeutic treatments to determine the most effective oncological treatmentsABANDONED—
044Medical testing for diagnostic or treatment purposes in the field of oncology and testing drug effectiveness; medical testing for diagnostic or treatment purposes; medical diagnostic testing, monitoring and reporting servicesABANDONED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 8, 2017MAB4ABANDONMENT NOTICE MAILED - INTER PARTES DECISION—
May 6, 2017ABN4ABANDONMENT - AFTER INTER PARTES DECISION—
May 6, 2017OP.TOPPOSITION TERMINATED NO. 999999—
May 6, 2017OP.SOPPOSITION SUSTAINED NO. 999999—
Jan 26, 2017OP.IOPPOSITION INSTITUTED NO. 999999—
Nov 4, 2016ETOFEXTENSION OF TIME TO OPPOSE RECEIVED—
Oct 18, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 18, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 28, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 12, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 5, 2016DOCKASSIGNED TO EXAMINER—
May 24, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
May 23, 2016NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance